CEO & Founder

Tzippi Cohen-Aharonson was born and educated in Israel, receiving a Bachelor of Science in Chemistry (cum laude) from the Hebrew University, Jerusalem and then a Masters in Neuro-Biochemistry (cum laude) from Tel Aviv University.

Her clinical research career began in 1996 and included senior positions for Quintiles Transnational Ltd. and Pharmanet Ltd.

tzippi portrateTzippi founded TCA Clinical Research Ltd. in 2006. Acting as CEO and manager for the company, Tzippi also fulfills her passion for onsite clinical research by offering personal freelance services. Tzippi has built a respected reputation in setting up and managing successful international and local clinical trials that comply with ICH GCP compliance. Tzippi is personally involved in every project ensuring adherence to the strictest quality and safety standards from conception through to implementation.

Tzippi's expertise reflects decades of experience, reaching across the following therapeutic areas – Oncology, Gastroenterology, Respiratory, Nephrology, Gene Therapy, Cardiovascular, Ophthalmology, Metabolic Disorders, Hematology, Hepatology, Pulmonary, Rheumatology, Psychiatry and Neurology.